Magazine Article | February 1, 2019

BeiGene Exec Talks Candidly About Quality, Compliance, And Outsourcing

Source: Life Science Leader

By Louis Garguilo, Chief Editor, Outsourced Pharma

It was time within our greater ruminations on China (see outsourcedpharma.com) to speak directly with a quality executive at a drug developer and manufacturer based there. That’s now been accomplished via a discussion with Diana Francis, VP of quality and compliance for BeiGene.

BeiGene is a biopharma developing and commercializing cancer drugs for global markets. It has been dubbed as a potential “Genentech of China.” The company also has locations in the U.S., Australia, and Europe.

VIEW THE MAGAZINE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Life Science Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: